There is a significant unmet medical need for antidepressants that are effective, rapid onset of action and to be well tolerated
This marks the fourth acquisition by Corona Remedies from multinational corporations
Enables additional US manufacturing capacity to serve increased demand for pharma/biotech customers
The agreement includes plans for distribution, technology transfer, local manufacturing, new pharmaceutical product development
GII is a leading investment firm with assets under management exceeding US$ 3.5 billion with presence across Saudi Arabia, UAE, Europe, USA and India
Finerenone significantly reduced the combined risk of cardiovascular death and total (first and recurrent) heart failure events,
The agency concluded that for people of all ages, IXCHI should be administered when there is a significant risk of chikungunya infection
Capricor’s BLA for Deramiocel received Priority Review in March 2025
Celecoxib is a nonsteroidal anti-inflammatory drug
New platform powered by Opentrons expands lab automation to accelerate scientific discovery
Subscribe To Our Newsletter & Stay Updated
